Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is ...

The 14-story medical school of I-277, the latest towering member of the Charlotte skyline, will begin enrolling in mid-July its first four-year class of 48 students. The goal is increasing ...

Catalyst Pharmaceuticals (NasdaqCM:CPRX) recently announced the appointment of William T. Andrews, MD, as Chief Medical Officer, a move that coincides with a 13% rise in the company's share price ...

Catalyst Pharmaceuticals (NasdaqCM:CPRX) recently announced the appointment of William T. Andrews, MD, as Chief Medical Officer, a move that coincides with a 13% rise in the company's share price over ...

Aktien » Nachrichten » CATALYST PHARMACEUTICALS AKTIE » Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer ...

CORAL GABLES, Fla. - Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), a pharmaceutical company currently trading near its 52-week high with an "EXCELLENT" financial health rating according to ...

Catalyst Pharmaceuticals appoints Dr. William Andrews as Chief Medical Officer, succeeding Dr. Gary Ingenito. Quiver AI Summary. Catalyst Pharmaceuticals has announced the appointment of Dr ...

Before founding Aletheia, Dr. Andrews served as a Chief Medical Officer for Flexion Therapeutics, ... PhD is retiring from Catalyst after a successful careerCORAL GABLES, Fla., June 02, 2025 ...

Catalyst Pharmaceuticals has provided a revenue guidance range for 2025 of $545-$565 million, with significant contributions expected from its products Firdapse, Agamry, and Fycompa.

Gary Ingenito, MD, PhD is retiring from Catalyst after a successful careerCORAL GABLES, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) ...

Catalyst, headquartered in Coral Gables, Fla., was recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the 2024 Deloitte Technology Fast 500™ list as ...

Gary Ingenito, MD, PhD is retiring from Catalyst after a successful career CORAL GABLES, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) ...